Other Liabilities, Noncurrent in USD of Enliven Therapeutics, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Enliven Therapeutics, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2021 to Q3 2025.
  • Enliven Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2025 was $103K.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)

Enliven Therapeutics, Inc. Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $103K +$103K Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $204K +$198K +3300% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $302K +$268K +788% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $0 -$67K -100% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $0 -$214K -100% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $6K -$354K -98.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $34K -$474K -93.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $67K -$592K -89.8% Dec 31, 2023 10-K 2025-03-13
Q3 2023 $214K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $360K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $508K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $659K -$55K -7.7% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $714K Dec 31, 2021 8-K 2023-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.